[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.238.62. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
The World in Medicine
October 14, 1998

Fewer Fractures

Author Affiliations
 

Not Available

Not Available

JAMA. 1998;280(14):1216. doi:10.1001/jama.280.14.1216-JWM80007-3-1

Several studies presented last month at the European Congress on Osteoporosis in Berlin, Germany, offered good news for the prevention of hip and spinal fractures in postmenopausal women and those with osteoporosis.

New results from a second phase of the US-based Fracture Intervention Trial that included 4432 women with thinning bones showed that the drug alendronate can reduce the risk of hip fractures by 56% in women who have never suffered a spinal fracture. The drug also was shown to reduce the risk of an initial spinal fracture by 49%.

First Page Preview View Large
First page PDF preview
First page PDF preview
×